Xcout Intel
Cytospire Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Cytospire Therapeutics among life sciences companies — ranked by similarity to what Cytospire Therapeutics actually does, not by market-cap band.
Subscribe to see Cytospire Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Cytospire Therapeutics
Cytospire Therapeutics Limited is a biotechnology research company based in London, United Kingdom. The company is focused on developing a portfolio of next-generation immune cell engagers to improve patients' lives.
Cytospire Therapeutics at a glance
Cytospire Therapeutics is a life sciences company headquartered in United Kingdom, founded in 2023. Its most recent funding round, Series A, raised $83M in May 2026. Xcout tracks 6 named people at Cytospire Therapeutics, including Natalie Mount (Chief Executive Officer, Board Director).
Cytospire Therapeutics leadership
- Natalie MountChief Executive Officer, Board Director
- Andrew FaddenChief Business Officer
- Peter GoodfellowNon-Executive Chair
- Alexis VandierNon-Executive Director, Servier Ventures
- Casper BreumNon-Executive Director, Sound Bioventures
- Samit HirawatNon-Executive Director
Cytospire Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $83M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Cytospire Therapeutics competitors
Ranked by semantic similarity — how close each company is to Cytospire Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
CytoImmune Therapeutics is a clinical-stage biotechnology company headquartered in Duarte, California, focused on developing novel cell therapies for cancer treatment.
Biotechnology
Centauri Therapeutics Limited is a privately held immunotherapy company with its primary headquarters located in London, United Kingdom.
Biotechnology
Alchemab Therapeutics Ltd is a biotechnology company headquartered in London, England, focused on pioneering patient-centric antibody discovery and development.
Biotechnology
Pheon Therapeutics is a biotechnology research company headquartered in London, England, that specializes in developing next-generation antibody-drug conjugates for hard-to-treat cancers.
Biotechnology
CytoSite BioPharma Inc. is a biotechnology company located in Boston, Massachusetts, engaged in commercial physical and biological research and development.
Biotechnology
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Biotechnology
Laverock Therapeutics is a biotechnology research company headquartered in London, England, that develops programmable advanced therapies.
Biotechnology
BriSTAR Immunotech Limited is a clinical-stage cell therapy company actively developing universal cell therapies with a differentiated product pipeline and offices in Beijing and Suzhou.
Biotechnology
KiraGen Bio is a Boston-based biotechnology company pioneering the development of AI-driven, multiplex gene-edited CAR-T cell therapies designed to target and block tumor suppression.
Biotechnology
Noile-Immune Biotech Inc. is a biotechnology company incorporated in 2015 and headquartered in Tokyo, Japan. The company specializes in the development of next-generation cancer immunotherapies, including advanced CAR-T cell technologies.
Biotech
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Biotechnology
Curon Biopharmaceutical is a clinical-stage biotechnology company developing antibody-based medicines, including bispecific antibodies, for cancer and other serious diseases. It serves patients and healthcare providers through the development of therapeutic biologics, with programs intended for oncology and immunology applications.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Cytospire Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Cytospire Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →